We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

77 hedge funds and large institutions have $421M invested in Translate Bio, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 12

125% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 8

15% more funds holding

Funds holding: 67 → 77 (+10)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

19% less capital invested

Capital invested by funds: $521M → $421M (-$100M)

Holders
77
Holders Change
+10
Holders Change %
+14.93%
% of All Funds
1.52%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
30
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.45M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$1.57M
3
RI
RTW Investments
New York
+$1.44M
4
Northern Trust
Northern Trust
Illinois
+$673K
5
State Street
State Street
Massachusetts
+$529K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$7.65M
2
MIM
Monashee Investment Management
Massachusetts
-$3.96M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$3.86M
4
DCM
DAFNA Capital Management
California
-$1.7M
5
HCM
Highbridge Capital Management
New York
-$1.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$141M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$65.4M -$1.07M -116,000 -1%
AVA
3
Atlas Venture Advisors
Massachusetts
$31.9M – – –
RI
4
RTW Investments
New York
$26.9M +$1.44M +156,180 +5%
BlackRock
5
BlackRock
New York
$25.7M +$3.45M +374,172 +13%
OFM
6
Omega Fund Management
Massachusetts
$19.8M – – –
FM
7
Frazier Management
Washington
$17.8M – – –
Federated Hermes
8
Federated Hermes
Pennsylvania
$17.1M +$459K +49,753 +2%
Vanguard Group
9
Vanguard Group
Pennsylvania
$13.9M -$3.86M -418,620 -20%
CCM
10
Camber Capital Management
Massachusetts
$12.2M – – –
RSCM
11
Rock Springs Capital Management
Maryland
$7.73M -$692K -75,000 -7%
AG
12
Artal Group
Luxembourg
$5.29M -$923K -100,000 -13%
State Street
13
State Street
Massachusetts
$5.05M +$529K +57,280 +10%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.45M +$347K +37,577 +7%
PA
15
Perceptive Advisors
New York
$3.54M – – –
BCPEMI
16
Bain Capital Public Equity Management II
Massachusetts
$3.39M – – –
Northern Trust
17
Northern Trust
Illinois
$3.34M +$673K +72,906 +22%
DCM
18
DAFNA Capital Management
California
$1.46M -$1.7M -184,384 -51%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$1.39M +$1.57M +170,209 New
Norges Bank
20
Norges Bank
Norway
$1.15M – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.04M +$233K +25,211 +25%
N
22
Nuveen
North Carolina
$958K -$3.09K -335 -0.3%
Charles Schwab
23
Charles Schwab
California
$702K +$109K +11,846 +16%
MFG
24
Magnus Financial Group
New York
$577K – – –
Morgan Stanley
25
Morgan Stanley
New York
$538K +$515K +55,842 +545%
1
2 3 4

TBIO Hedge Fund Activity: Q4 2019 in Review

77 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q4 2019, worth a combined $421M — down 19% from $521M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TBIO positions and 8 closed out — a net gain of 10 holders — while 30 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $3.45M. The largest seller was Citigroup, cutting an estimated $7.65M.

  • 77 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q4 2019, up from 67 in Q3 2019.
  • Funds reported $421M of Translate Bio, Inc. Common Stock stock for Q4 2019, down 19% quarter-over-quarter.
  • 18 funds opened new Translate Bio, Inc. Common Stock positions in Q4 2019 and 8 closed out, a net change of +10 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q4 2019 was BlackRock, an estimated $3.45M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q4 2019 was Citigroup, an estimated $7.65M sold.

Based on aggregated 13F filings for Q4 2019.